Search results for "Location"

showing 10 items of 1480 documents

LUSSAZIONE DISSOCIATA DEL SEMILUNARE E DELLE OSSA DEL CARPO: CASE REPORT

2014

CARPUS LUNATE DISLOCATION DISSOCIATED CLASSIFICATIONSettore MED/33 - Malattie Apparato Locomotore
researchProduct

Searching for the right timing of surgical delay: angiogenesis, vascular endothelial growth factor and perfusion changes in a skin-flap model.

2009

Summary Background The angiogenic potential of vascular endothelial growth factor (VEGF) and its oxygen pressure-dependent regulation suggest a strong connection between this growth factor and the ‘delay phenomenon'. In this study we focused on the chronological changes in VEGF concentration and flap perfusion in order to optimise the duration of surgical delay. Methods The VEGF concentration in skin and underlying muscle was measured in oversized, random-pattern flaps on 38 male Sprague-Dawley rats after 3, 5 or 7 days of surgical delay. Additionally, flaps were raised 5 or 7 days past preconditioning. The effect on flap perfusion was measured using indocyanine green fluoroscopy and the si…

CD31Graft RejectionMalemedicine.medical_specialtyTime FactorsAngiogenesismedicine.medical_treatmentNeovascularization PhysiologicVasodilationEnzyme-Linked Immunosorbent AssayStatistics NonparametricSurgical FlapsNeovascularizationRats Sprague-Dawleychemistry.chemical_compoundRandom AllocationLaser-Doppler FlowmetryMedicineAnimalsProbabilitySkinbusiness.industryVascular Endothelial Growth FactorsGrowth factorMicrocirculationGraft SurvivalSkin TransplantationSurgeryRatsVascular endothelial growth factorDisease Models AnimalchemistryMultivariate AnalysisSurgerymedicine.symptombusinessIndocyanine greenPerfusionBiomarkersJournal of plastic, reconstructiveaesthetic surgery : JPRAS
researchProduct

Who should get COVID-19 vaccine first? A survey to evaluate hospital workers’ opinion

2021

Prospective planning of COVID-19 vaccines allocation will be essential to maximize public health and societal benefits while preserving equity. Decisions about how to allocate limited supplies of vaccines need to be clear about the criteria used in setting priorities, with a specific commitment to transparency and communication. The aim of our study was to think through these competing demands, focusing on the opinion of healthcare workers (HCWs). The primary endpoint of the study was to assess the opinion of all the HCWs in a University based Italian Hospital about the fairest priority order to COVID 19 vaccines and to understand on which criteria the prioritization preferences of HCWs are…

COVID-19 vaccine; prioritization; allocation; distribution; public health ethics; healthcare workersmedicine.medical_specialty030231 tropical medicineImmunologyPopulationeducationPsychological interventionlcsh:MedicineAllocation COVID-19 vaccine Distribution Healthcare workers Prioritization Public health ethicsArticleHerd immunity03 medical and health sciences0302 clinical medicineallocationDrug DiscoveryHealth caremedicinedistributionPharmacology (medical)030212 general & internal medicineeducationMultiple choicePharmacologyeducation.field_of_studypublic health ethicsbusiness.industryhealthcare workersPublic healthlcsh:RLaw enforcementprioritizationVaccinationInfectious DiseasesFamily medicinebusinessCOVID-19 vaccine
researchProduct

The Right to Health and Resource Allocation. Who Gets What and Why in the COVID-19 Pandemic

2022

The COVID-19 outbreak has led to a worldwide, substantial increase in the demand for pharmaceuticals, hospital beds, ventilators, and medical supplies. When needs suddenly exceed demand worldwide, resources may quickly become scarce with potential demand, so that strict rationing is the only viable response. Against this backdrop, this chapter scrutinizes the rationales for the prioritization of scarce resources. It questions the essential role and reaches the market concerning resources essential to delivering health care, especially in severe shortages, such as during a global pandemic.

COVID-19 resource allocation right to healthSettore IUS/02 - Diritto Privato Comparato
researchProduct

Channel Assembling with Priority-Based Queues in Cognitive Radio Networks: Strategies and Performance Evaluation

2014

[EN] With the implementation of channel assembling (CA) techniques, higher data rate can be achieved for secondary users in multi-channel cognitive radio networks. Recent studies which are based on loss systems show that maximal capacity can be achieved using dynamic CA strategies. However the channel allocation schemes suffer from high blocking and forced termination when primary users become active. In this paper, we propose to introduce queues for secondary users so that those flows that would otherwise be blocked or forcibly terminated could be buffered and possibly served later. More specifically, in a multi-channel network with heterogeneous traffic, two queues are separately allocate…

CTMCQueueing theoryChannel allocation schemesbusiness.industryComputer scienceApplied MathematicsCognitive radio networksMarkov processINGENIERIA TELEMATICABlocking (statistics)Computer Science ApplicationsScheduling (computing)Continuous-time Markov chainChannel assemblingsymbols.namesakeCognitive radioHeterogeneous trafficsymbolsQueuing schemesElectrical and Electronic EngineeringbusinessQueueCommunication channelComputer networkIEEE Transactions on Wireless Communications
researchProduct

PHEA-graft-polymethacrylate supramolecular aggregates for protein oral delivery

2013

Abstract Salmon calcitonin (sCT) is characterized by a poor oral availability. A new copolymer, β-poly(N-2-hydroxyethyl)-graft-{N-2-ethylene[2-poly(methacrylic acid sodium salt)isobutyrate]}- d , l -aspartamide (PHEA-IB-p(MANa + )), was designed for the oral administration of sCT through the formation of supramolecular aggregates (SAs) based on electrostatic interactions. Several sCT/PHEA-IB-p(MANa + ) weight ratios were characterized by turbidimetry, DLS, zeta potential, and microscopy analysis. After the incubation of sCT/PHEA-IB-p(MANa + ) complex with digestive enzymes, 10% (w/w) of loaded sCT was released in the native form. In vitro investigation was carried out to determine the copol…

Calcitoninmedicine.medical_specialtypeptide deliveryAdministration OralPharmaceutical Sciencechemistry.chemical_elementPeptidePharmacologyCalciumRats Sprague-DawleyRandom AllocationDrug Delivery SystemsPolymethacrylic AcidsPharmacokineticsimmune system diseasesOral administrationhemic and lymphatic diseasesmedicineAnimalsHumansPolyhydroxyethyl Methacrylatechemistry.chemical_classificationDrug CarriersGeneral Medicineoral deliveryRatsBioavailabilitySurgeryoral delivery; peptide delivery; calcitoninsurgical procedures operativechemistryCalcitoninSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoPharmacodynamicsFemaleTurbidimetryCaco-2 CellsPeptidestherapeuticshuman activitiesPHEA oral delivery osteoporosis supramolecolar aggregates peptide almon calcitoninBiotechnology
researchProduct

A biphasic calcium phosphate coating for potential drug delivery affects early osseointegration of titanium implants.

2016

Background Calcium phosphate (CaP) surface coatings may accelerate osseointegration and serve as a drug delivery system for mineral-binding biomolecules. In a pilot study, the impact of a commercially available, thin CaP coating on early osseous bone remodeling was compared with a modern, subtractive-treated rough surface (SLA-like) in an animal trial. Methods In 16 rabbits, 32 endosseous implants (CaP; n = 16, SLA-like; n = 16) were bilaterally inserted in the proximal tibia after randomization. After 2 and 4 weeks, bone-implant contact (BIC;%) in the cortical (cBIC) and the trabecular bone (sBIC) as well as volume of bone within the screw thread with the highest amount of new-formed bone …

Calcium PhosphatesCancer Researchchemistry.chemical_elementDentistry02 engineering and technologyengineering.materialCalciumOsseointegrationPathology and Forensic MedicineBone remodeling03 medical and health sciencesRandom Allocation0302 clinical medicineDrug Delivery SystemsCoatingOsseointegrationAnimalsDental ImplantsTitaniumChemistrybusiness.industryfungiDental Implantation Endosseous030206 dentistry021001 nanoscience & nanotechnologyBiphasic calcium phosphateTrabecular boneOtorhinolaryngologyDental Prosthesis DesignDrug deliveryModels AnimalengineeringPeriodonticsRabbitsOral Surgery0210 nano-technologyNuclear medicinebusinessTitaniumJournal of oral pathologymedicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
researchProduct

Abstract 4107: Targeted re-sequencing of neuroblastoma tumors reveals chromosomal rearrangements that involve the Anaplastic Lymphoma Kinase (ALK) ge…

2013

Abstract Neuroblastoma (NBL) is a cancer of early childhood arising from the developing sympathetic nervous system. NBL tumors display a broad clinical and biological heterogeneity, ranging from highly aggressive tumors with fatal outcome to tumors with spontaneous regression. Recurrent mutations are mainly only observed in Anaplastic Lymphoma Kinase (ALK), which is involved in the pathogenesis of both familiar and sporadic NBL. ALK encodes a tyrosine kinase receptor with importance in neuronal development and was initially characterized in anaplastic large cell lymphoma from a translocation leading to the NPM-ALK fusion protein. Subsequent studies show that additional ALK chimeras have bee…

Cancer ResearchChromosomal translocationBiologyAmpliconmedicine.diseaseFusion proteinMolecular biologyExonOncologyhemic and lymphatic diseasesNeuroblastomamedicineAnaplastic lymphoma kinaseKinase activityAnaplastic large-cell lymphomaCancer Research
researchProduct

EML4-ALK translocation identification in RNA exosomal cargo (ExoALK) in NSCLC patients: A novel role for liquid biopsy

2019

Abstract: The introduction of druggable targets has significantly improved the outcomes of non-small cell lung cancer patients (NSCLC). EML4-ALK translocation represents 4-6% of the druggable alterations in NSCLC. With the approval of Crizotinib, first discovered drug for the EML4-ALK translocation, on first line treatment for patients with detected mutation meant a complete change on the treatment landscape. The current standard method for EML4-ALK identification is immunohistochemistry or FISH in a tumor biopsy. However, a big number of NSCLC patients have not tissue available for analysis and others are not suitable fir biopsy due to their physical condition or the location of the tumor.…

Cancer ResearchLiquid biopsybiomarkersNon-small cell lung cancer (NSCLC)ALK translocationBiomarkerExosomesExosomeOncologyPerspectiveRadiology Nuclear Medicine and imagingHuman medicineBiomarkers:Ciencias de la Salud::Oncología [Materias Investigacion]
researchProduct

The BCL6 gene in B-cell lymphomas with 3q27 translocations is expressed mainly from the rearranged allele irrespective of the partner gene

2003

The BCL6 gene, which functions as a transcription repressor, is the target of multiple chromosomal translocations in non-Hodgkin's lymphomas (NHL). These translocations occur in the nontranslated region of the BCL6 gene, juxtaposing regulatory sequences of the diverse partner genes to the open reading frame of the BCL6 gene and thus are thought to deregulate BCL6 gene expression. The levels of expression of the BCL6 gene and protein have been demonstrated to predict the clinical outcome of diffuse large B-cell lymphomas. By contrast, the prognostic significance of BCL6 gene translocations is unclear. In this study we have sought an explanation for this apparent discrepancy. We examined tumo…

Cancer ResearchLymphoma B-CellBiologyTranslocation Geneticimmune system diseasesProto-Oncogene Proteinshemic and lymphatic diseasesGene expressionTumor Cells CulturedHumansRNA MessengerAllelePromoter Regions GeneticGeneAllelesGene RearrangementGeneticsRegulation of gene expressionPromoterHematologyGene rearrangementBCL6Neoplasm ProteinsDNA-Binding ProteinsGene Expression Regulation NeoplasticRepressor ProteinsOncologyRegulatory sequenceMutationProto-Oncogene Proteins c-bcl-6Cancer researchChromosomes Human Pair 3Transcription FactorsLeukemia
researchProduct